 |
|
OHSU scientists partner with others to form center aimed at combating infectious diseases
April 16, 2009The Pacific Northwest Regional Center for Excellence will bring together vaccine and infectious disease researchers from Oregon, Washington, Idaho and Alaska
PORTLAND, Ore. -- Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.
Based at OHSU, the collaborative Pacific Northwest Regional Center for Excellence (PNWRCE) for Biodefense and Emerging Infectious Diseases was established through a five-year, $40.7 million cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health. Jay Nelson, Ph.D., is director of the PNWRCE and OHSU's Vaccine and Gene Therapy Institute (VGTI), and Michael Katze, Ph.D., UW professor of microbiology, is co-director of the PNWRCE.
"Since the anthrax attacks in 2001, the country has rapidly expanded our ability to detect and combat infectious diseases whether they are spread naturally or through a bioterrorist attack," said Dr. Nelson. "These regional research centers located across the country serve to better protect the population while at the same time conducting research aimed at preventing or successfully combating a public health crisis -- recent examples would include threats posed in the past few years by influenza, West Nile virus and SARS."
Members of the PNWRCE will work closely with public health departments in all participating Northwest states in training and research. The members will also collaborate with newly funded science initiatives within the state such as the Oregon Translational Research and Drug Development Institute. OTRADI provides crucial research services to Oregon researchers involved in pharmaceutical development and will be an important partner in the research.
PNWRCE researchers will study a broad range of diseases and viruses, including Ebola, Dengue, SARS, avian and 1918 influenza, dengue fever, yellow fever, and West Nile, all of which are caused by pathogens that NIAID categorizes as A, B and C. NIAID priority pathogens in category A are the most dangerous and include Ebola and Dengue.
The PNWRCE will focus on two main areas to identify potential therapeutic targets for infectious disease: 1) research investigating defects in the immune system caused by aging, and 2) the study of disease-host interactions through newly advanced techniques in genomics and genetic analyses. Both research areas will facilitate the development of vaccines and other therapies.
Janko Nikolich-Zugich, M.D., Ph.D., an expert in the immunology of the aged, will lead theme one of the PNWRCE project, "Identifying Immune Defects in the Aged Immune Systems." Mark Slifka, Ph.D., associate scientist, OHSU VGTI, will investigate "Yellow Fever Vaccination of the Elderly and Immune Compromised".
"The increasing incident of newly emerging disease requires novel approaches in the development of new therapeutics," Katze said. "Our program at the University of Washington in genomic technologies will dovetail nicely with the research proposed in the PNWRCE. We look forward to this unique collaborative effort between our two universities."
Katze will use systems-level approaches to define potential therapeutic targets in pathogenesis and immunity, one of two major PNWRCE projects that will take place at the UW. Michael Gale Jr., UW associate professor of immunology, is the principal investigator of a second project, "Pro- and Anti-Viral Host Pathways in Flavivirus Pathogenesis." Both the Washington National Primate Research Center at UW and the Oregon National Primate Research Center at OHSU will play prominent roles in the new center.
The 11 federally funded centers for excellence exist in 10 different multi-state regions of the country - regions defined by the National Institutes of Health. The northwest region (region 10) includes Alaska, Idaho, Oregon and Washington. Two regional centers exist in region 10: the new PNWRCE based at OHSU and another previously founded center based at the University of Washington. Region 10 is the only region in the country that is home to two regional centers.
"We are delighted to participate in this NIAID program," said Dan Dorsa, Ph.D., OHSU vice president for research. "The Northwest has some of the best immunology, virology and bacterial experts in the world, and the formation of this center provides an extraordinary opportunity to combine the expertise of these individuals in the fight against infectious disease. We also feel that this partnership with the University of Washington will provide the seed for future opportunities between our two institutions."
Oregon Health & Science University
"Since the anthrax attacks in 2001, the country has rapidly expanded our ability to detect and combat infectious diseases whether they are spread naturally or through a bioterrorist attack," said Dr. Nelson. "These regional research centers located across the country serve to better protect the population while at the same time conducting research aimed at preventing or successfully combating a public health crisis -- recent examples would include threats posed in the past few years by influenza, West Nile virus and SARS."
Members of the PNWRCE will work closely with public health departments in all participating Northwest states in training and research. The members will also collaborate with newly funded science initiatives within the state such as the Oregon Translational Research and Drug Development Institute. OTRADI provides crucial research services to Oregon researchers involved in pharmaceutical development and will be an important partner in the research.
PNWRCE researchers will study a broad range of diseases and viruses, including Ebola, Dengue, SARS, avian and 1918 influenza, dengue fever, yellow fever, and West Nile, all of which are caused by pathogens that NIAID categorizes as A, B and C. NIAID priority pathogens in category A are the most dangerous and include Ebola and Dengue.
The PNWRCE will focus on two main areas to identify potential therapeutic targets for infectious disease: 1) research investigating defects in the immune system caused by aging, and 2) the study of disease-host interactions through newly advanced techniques in genomics and genetic analyses. Both research areas will facilitate the development of vaccines and other therapies.
Janko Nikolich-Zugich, M.D., Ph.D., an expert in the immunology of the aged, will lead theme one of the PNWRCE project, "Identifying Immune Defects in the Aged Immune Systems." Mark Slifka, Ph.D., associate scientist, OHSU VGTI, will investigate "Yellow Fever Vaccination of the Elderly and Immune Compromised".
"The increasing incident of newly emerging disease requires novel approaches in the development of new therapeutics," Katze said. "Our program at the University of Washington in genomic technologies will dovetail nicely with the research proposed in the PNWRCE. We look forward to this unique collaborative effort between our two universities."
Katze will use systems-level approaches to define potential therapeutic targets in pathogenesis and immunity, one of two major PNWRCE projects that will take place at the UW. Michael Gale Jr., UW associate professor of immunology, is the principal investigator of a second project, "Pro- and Anti-Viral Host Pathways in Flavivirus Pathogenesis." Both the Washington National Primate Research Center at UW and the Oregon National Primate Research Center at OHSU will play prominent roles in the new center.
The 11 federally funded centers for excellence exist in 10 different multi-state regions of the country - regions defined by the National Institutes of Health. The northwest region (region 10) includes Alaska, Idaho, Oregon and Washington. Two regional centers exist in region 10: the new PNWRCE based at OHSU and another previously founded center based at the University of Washington. Region 10 is the only region in the country that is home to two regional centers.
"We are delighted to participate in this NIAID program," said Dan Dorsa, Ph.D., OHSU vice president for research. "The Northwest has some of the best immunology, virology and bacterial experts in the world, and the formation of this center provides an extraordinary opportunity to combine the expertise of these individuals in the fight against infectious disease. We also feel that this partnership with the University of Washington will provide the seed for future opportunities between our two institutions."
Oregon Health & Science University
Infectious Diseases Current Events and Infectious Diseases News RSSPreventing H1N1 spread to health care workers: Dilemma, debate and confusion
A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers.
New findings suggest strategy to help generate HIV-neutralizing antibodies
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases
The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells.
Texas A&M Researchers Examine How Viruses Destroy Bacteria
Viruses are well known for attacking humans and animals, but some viruses instead attack bacteria. Texas A&M University researchers are exploring how hungry viruses, armed with transformer-like weapons, attack bacteria, which may aid in the treatment of bacterial infections.
Pivotal study for PSD502 -- the first potential treatment for premature ejaculation
At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).
Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria
A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease.
Small nanoparticles bring big improvement to medical imaging
If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging.
New explanation for nature's hardiest life form
Got food poisoning? The cause might be bacterial spores, en extremely hardy survival form of bacteria, a nightmare for health care and the food industry and an enigma for scientists.
Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor
This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities.
Researchers mobilizing global resources to test new treatments for severe H1N1 infection
An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic.
More Infectious Diseases Current Events and Infectious Diseases News Articles
 |
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: Expert Consult Premium Edition - Enhanced Online Features and Print by Gerald L. Mandell (Author) After thirty years, PPID is still the reference of choice for comprehensive, global guidance on diagnosing and treating the most challenging infectious diseases. Drs. Mandell, Bennett, and Dolin have substantially revised and meticulously updated, this new edition to save you time and to ensure you have the latest clinical and scientific knowledge at your fingertips. With new chapters, expanded and updated coverage, increased worldwide perspectives, and many new contributors, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th Edition helps you identify and treat whatever infectious disease you see. And, as an Expert Consult title with enhanced online features, this updated 7th edition comes with convenient access to the full text online, regular... |
 |
Infectious Diseases: A Clinical Short Course, Second Edition (LANGE Clinical Medicine) by Frederick Southwick (Author) Gain a full understanding of clinical infectious diseases in just thirty days A Doody's Core Title! No other resource makes clinical infectious diseases more manageable and easy to master than Infectious Diseases: A Clinical Short Course. This one-of-a-kind self-instruction tool is organized by system/region as opposed to pathogens -- simulating how common pathogens and disorders would be encountered in rounds or in practice. For this reason, this remarkable resource is unsurpassed for learning how to associate pathogens with their corresponding impact on actual patients. Features: A true, concise “short course” format that can be read and understood in the span of a 30-day infectious disease rotation Numerous case examples... |
 |
Clinical Infectious Disease by David Schlossberg (Editor) This clinically-oriented, user-friendly text is the best on the market for infectious disease. Complete and comprehensive, Schlossberg's text will be an effective reference for any practitioner who may encounter these afflictions. The orientation of the volume is multi-faceted: in addition to the traditional organization of organ system and pathogen-related information, this text includes specific sections on the susceptible host, travel-related infections, nosocomial infections, infections related to trauma, and bioterrorism. The information on post-surgical infections will be of great interest to practicing surgeons. Informative algorithms, tables, and high-quality color photographs supplement many of the chapters in this conveniently-sized volume. For practicality and ease of use, one... |
 |
Infectious Diseases, Second Edition (EXPERT GUIDE SERIES- AMERICAN COLLEGE OF PHYSICIANS) by James S. Tan (Editor), Michael J. Tan (Editor), Robert A. Salata (Editor), Thomas M. File Jr. (Editor) Here s the expert guidance practitioners need to diagnose and treat the most commonly encountered infections! This fully revised and updated New Edition keeps readers current with the latest etiologic agents, the most appropriate diagnostic tests, and the most effective management options. The 2nd Edition features new chapters on Antimicrobial Agents for the Primary Care Physician and Prosthetic Joint Infections. FEATURES: -Examines infections of the central nervous system, heart and blood vessels, gastrointestinal tract, genitourinary system, respiratory tract, skeletal system, and the skin. -Features individual chapters on HIV, herpes virus, Lyme disease, and malaria. -Puts key information at the reader s fingertips with diagnostic and treatment tables throughout the text. -Reviews... |
 |
Infectious Disease: A Scientific American Reader (Scientific American Readers) by Scientific American (Editor) The international public health scare that resulted last year when a man infected with multidrug-resistant tuberculosis flew overseas from the United States and back illustrates both the fear and the potential impact of highly infectious diseases in a global age. At a time when scientists warn of the potential for an influenza epidemic to rival the deadly outbreak of 1919 and newspapers feature alarming headlines about incidences of mad cow disease, infectious disease will be a critical area of concern and scientific study in the twenty-first century. Infectious Disease collects thirty of the most exciting, innovative, and significant articles on communicable illness published in the pages of Scientific American magazine since 1993. With sections devoted to viral infections,... |
 |
Infectious Diseases (Infectious Diseases ( Gorbach )) by Sherwood L Gorbach (Editor), John G Bartlett (Editor), Neil R Blacklow (Editor) Tufts Univ. School of Medicine, Boston, MA. Provides comprehensive guidelines on the diagnosis, treatment, and prevention of every infectious disease seen in current clinical practice. Discusses new information on hospital infections, bioterrorism, toxic shock syndrome, West NIle virus, hepatitis, and more. Previous edition: c1998. DNLM: Communicable Diseases. |
 |
The A to Z of Infectious Diseases (Concise Encyclopedia) by Carol Turkington (Author), Bonnie Lee, M.d. Ashby (Author) In the past 25 years, more than 30 new germs affecting humans have emerged onto the medical scene, most of them rising from animals. New diseases like the avian flu, Ebola, SARS, and weaponized viruses such as anthrax and smallpox pose a growing danger to the world. With the threat of infectious diseases remaining constant, it is essential to have clear and concise information on this topic. "The A to Z of Infectious Diseases" provides more than 600 up-to-date entries covering the latest research, new treatments and vaccines, and rising diseases such as mad cow disease. Appendixes include drugs used to treat infectious diseases, tips for home disinfection, and lists of helpful organizations and publications, making this the ultimate resource for knowledge about infectious diseases. Topics... |
 |
Infectious Disease Epidemiology: Theory And Practice by Kenrad E., M.D. Nelson (Author), Carolyn F. Masters, Ph.D. Williams (Author) This thorough revision contains new chapters on principles of immunology, measles and polio, meningococcal infections, including pneumococcal, and influenza infections. The chapter on emerging infections has been divided into one of mosquito borne infections and includes West Nile Virus, Rift V and Dengue as well as other arthropod borne infections. SARS and Monkey Poxare included in the new chapter. All other chapters have been updated. |
 |
Case Studies in Infectious Disease by Peter Lydyard (Author), Michael Cole (Author), John Holton (Author), Will Irving (Author), Nino Porakishvili (Author), Pradhib Venkatesan (Author), Kate Ward (Author) Case Studies in Infectious Disease presents forty case studies featuring the most important human infectious diseases worldwide. Written for students of microbiology and medicine this book describes the natural history of infection from point of entry of the pathogen through pathogenesis, followed by clinical presentation, diagnosis and treatment. Five core sets of questions are posed in each case. What is the nature of the infectious agent, how does it gain access to the body, what cells are infected, and how does the organism spread? What are the host defense mechanisms against the agent and how is the disease caused? What are the typical manifestations of the infection and the complications that can occur? How is the infection diagnosed and what is the... |
 |
Current Diagnosis & Treatment In Infectious Diseases (Current Diagnosis and Treatment in Infectious Diseases) by Walter R. Wilson (Author) Numerous quick-access boxes and tables summarize key information on one of the leading causes of death. This title covers the essentials of diagnosis, syndromes in children and adults, and treatments, including first and second-choice options. It blends practice-oriented, authoritative coverage with just the right amount of microbiology for understanding diagnostic and management decisions. |
| © 2009 BrightSurf.com |